Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Global Blood Therapeutics, Inc. (GBT)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -303.1-247.6-266.8-174.2-117.0-82.5-46.4-23.8
Depreciation and amortization  5.98.38.64.61.71.20.90.7
Stock-based compensation  78.771.545.730.113.79.23.20.4
Change in working capital   [+]39.844.026.24.78.04.323.58.3
Other operating activities  -78.1-88.1-8.1-0.60.70.1-12.2-5.6
Cash from operations  -256.8-211.9-194.4-135.4-93.0-67.7-30.9-20.1
   
Capital expenditures   [+]-3.2-8.8-3.5-4.8-3.3-1.4-1.0-0.3
Purchases of short-term investments, net  15.3326.1-73.4-179.4-31.7-105.5  
Other cash from investing         -0.1
Cash from investing  12.1317.3-76.9-184.2-35.0-106.9-1.0-0.4
   
Issuance of common stock, net  46.1 219.4396.5232.0117.0126.2 
Option exercises        2.10.5
Other cash from financing  388.287.178.71.43.21.14.269.8
Cash from financing  434.387.1298.2397.9235.2118.1128.369.3
   
Free cash flow  -260.0-220.6-197.9-140.2-96.1-69.1-31.9-20.4
        Per share (diluted)  ($4.13)($3.60)($3.39)($2.74)($2.27)($2.08)($2.49)($12.21)
   
Cash paid for interest  13.96.3      

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy